Sometimes yes, sometimes no. It comes down to your plan type, your diagnosis, and a bit of luck with your employer’s drug list. About 4 in 10 commercial insurance plans cover Wegovy for weight loss in 2026, and almost all require prior authorization first. Medicare and Medicaid follow their own separate rules, which we’ll break down below.
Quick Verdict
Best shot at coverage: People with employer commercial insurance whose plan lists obesity treatment as a benefit, or anyone with heart disease being prescribed Wegovy to lower cardiovascular risk.
Should plan to pay cash: Most Medicaid enrollees, most Medicare Part D members without heart disease or MASH, and anyone whose employer plan excludes weight loss drugs entirely. That’s common, and it’s growing.
Current cash price: Novo Nordisk’s own site lists Wegovy starting at $199 a month for your first two fills through NovoCare Pharmacy, then $349 a month after that. More on that below.
Does Insurance Cover Wegovy? It Depends on Three Things
The honest answer to does insurance cover Wegovy is: it depends on your plan type, why your doctor is prescribing it, and whether your employer chose to include weight loss drugs in your benefits.
Wegovy is FDA-approved for three separate reasons now. Chronic weight management, lowering heart attack and stroke risk in people with existing heart disease, and a liver condition called MASH. Insurance plans often treat these three uses completely differently, even though it’s the same drug in the same pen.
That’s the part most people miss. If your plan says no to weight loss coverage, ask your doctor whether you’d also qualify under the heart disease or MASH indication. Same drug, different door in.
Commercial and Employer Insurance
This is where most working-age adults live, and coverage has gotten worse here, not better, over the past year.
As of mid 2026, about 9% of people with commercial insurance have unrestricted coverage for Wegovy, down slightly from 10% in 2025. Another 77% have coverage with restrictions like prior authorization, step therapy, or a BMI cutoff. And 7% of people with commercial insurance, close to 13 million people, have no coverage at all.
Big insurers like Cigna, Aetna, and Blue Cross Blue Shield can cover Wegovy, but your employer decides. Some large employer plans have dropped weight loss GLP-1 coverage entirely to control costs. If your HR department switched carriers or plan designs this year, check your new formulary. Don’t assume last year’s coverage carried over.
If you’re covered, expect a copay between $25 and $500 a month depending on your drug tier. First-try prior authorization denials happen 35 to 45% of the time, but appeals succeed in roughly 60% of cases with solid documentation, including your BMI history, prior weight-loss attempts, and any related conditions. [link: How to Appeal a Wegovy Denial]
Check before you call your insurer: log into your member portal and search the formulary for “Wegovy” or “semaglutide,” look for “obesity” or “chronic weight management” as a covered indication, and ask what documentation your doctor needs for prior authorization.
Medicare and Wegovy
This one’s kind of confusing, gonna be honest. Medicare has never covered weight loss drugs on their own. That’s been federal law since Part D started in 2006, back when obesity was treated as a cosmetic issue rather than a medical one.
Two things changed that. In 2024, the FDA approved Wegovy for reducing heart attack and stroke risk in people with existing heart disease. Since that’s not a weight loss indication, Part D plans gained the ability to cover it if your plan lists it on the formulary and you meet clinical criteria. Same goes for MASH.
Then, on July 1, 2026, CMS launched the Medicare GLP-1 Bridge, a temporary program letting eligible Part D members get Wegovy for weight management at a flat $50 copay a month, through the end of 2027. You’re not eligible for the Bridge if you already have type 2 diabetes, sleep apnea, or MASH, since those already have their own coverage path.
One more thing: Medicare beneficiaries can’t use the manufacturer’s cash pay savings offers. Those are for commercially insured or uninsured patients only.
Medicaid and Wegovy
Medicaid coverage for Wegovy is genuinely messy right now, and it changes state by state, sometimes month by month. As of 2026, somewhere around 13 to 19 states cover GLP-1 drugs like Wegovy for weight loss specifically, and that number has been shrinking. California, New Hampshire, Pennsylvania, and South Carolina all dropped weight-loss GLP-1 Medicaid coverage at the start of 2026, citing cost.
Every state Medicaid program still covers GLP-1 drugs for type 2 diabetes. It’s specifically the weight loss indication states are cutting. Where it is covered, expect strict prior authorization: a documented BMI over 30 (or over 27 with a related condition), plus proof of diet and exercise attempts. [link: Medicaid GLP-1 Coverage by State]
Because this shifts so often, call your state Medicaid member services line or check your plan’s preferred drug list directly. Don’t trust an old article, including, honestly, parts of this one. Rules move fast here.
What If Insurance Doesn’t Cover Wegovy?
If your plan says no, you’ve still got real options. Here’s what the actual prices look like right now, straight from each source’s own site.
NovoCare (Direct From Novo Nordisk)
Novo Nordisk sells Wegovy directly through its own site and pharmacy, and this is honestly where I’d start if insurance is a no for you.
The official list price is $1,349.02 per package for the pen, pill, and HD pen. Almost nobody pays that. With commercial insurance that covers Wegovy, the manufacturer’s savings offer can bring your copay to as little as $25 a month, capped at $100 in savings. Government insurance beneficiaries don’t qualify.
Uninsured, or your insurance says no? You can buy through NovoCare Pharmacy directly. Their site currently lists $199 a month for your first two fills at the 0.25 mg or 0.5 mg starting doses, then $349 a month after that for standard doses, and $399 a month for the HD 7.2 mg pen. That offer runs through the end of 2026 per their site today.
Good for: anyone comfortable managing their own prescription without a membership fee. Skip if: you want built-in coaching or help chasing your insurance company.
Hims
Hims sells GLP-1s through a required membership and has moved almost entirely to branded, FDA-approved products after settling a legal dispute with Novo Nordisk earlier in 2026.
On Hims’s own pricing page today, the Wegovy pill starts at $149 a month, and the Wegovy pen starts at $199 a month, medication only. You also need an active Weight Loss Membership: $39 for month one, then $149 a month after that, billed separately. So your real starting cost for the pen, membership included, runs around $348 in month one and roughly the same or more each month after.
Hims states plainly that insurance isn’t required, and they don’t appear to bill insurance for medication either. It’s cash pricing either way. The medication fee is FSA and HSA eligible, though the membership fee itself isn’t.
Common complaint: the separate membership fee catches new customers off guard, and Hims relies on async, message-based visits in many states rather than live video.
Good for: an all-online process with no waiting room. Skip if: you already have insurance coverage, since Hims’s cash price won’t beat a covered copay.
Ro (Ro Body)
Ro runs a similar model. A required Body membership, with medication billed on top.
Per Ro’s official pricing page, the Body membership costs $39 for month one, then $149 a month, or as low as $74 a month if you prepay a full year. Medication is separate: the Wegovy pill starts at $149 a month, and the pen starts at $199 a month, rising with dose.
Where Ro stands out is insurance help. They offer a free GLP-1 Insurance Checker, and membership includes a concierge team that will work with your insurer on your behalf if your plan covers part of the cost. Genuinely useful if calling your insurance company yourself sounds exhausting.
Common complaint: after 24 provider messages a year, extra consults run $15 each, and like Hims, amounts paid through Ro don’t count toward your deductible.
Good for: help navigating insurance without doing the calling yourself. Skip if: you want the cheapest possible cash price with no extras, since NovoCare direct will usually beat it.
Wegovy Cost Comparison Table
| NovoCare (direct) | $199/mo first 2 fills, then $349/mo | None, no membership | Savings card only, self service |
| Hims | $199/mo (pen), plus membership | $39 first month, $149/mo membership | Not required, cash pay model |
| Ro (Ro Body) | $199/mo (pen), plus membership | $39 first month, $149/mo (or $74/mo prepaid annual) | Free insurance checker plus concierge team |
Pick NovoCare direct if you already know your dose and don’t want a membership fee. Pick Ro if you want help fighting for insurance coverage. Pick Hims if you want a fully async, app-based experience.
[link: Best GLP-1 Programs page] [link: Wegovy Savings Card Guide] [link: Zepbound vs Wegovy Insurance Coverage]
FAQ
Does insurance cover Wegovy for weight loss, or just other conditions? Depends entirely on your plan. Some cover the weight loss indication outright. Others only cover cardiovascular risk reduction or MASH. Ask your insurer which indications your formulary allows.
Will my insurance require prior authorization? Almost certainly yes. Nearly all plans that cover Wegovy require it, plus documented BMI, a diagnosis, and proof of prior weight loss attempts.
What happens if my prior authorization gets denied? You can appeal. Appeals succeed in roughly 6 out of 10 cases with thorough documentation. Ask your provider’s office for help. [link: How to Appeal a Wegovy Denial]
Does Medicare cover Wegovy in 2026? Only for cardiovascular risk reduction or MASH through standard Part D, or through the Medicare GLP-1 Bridge for weight management, a flat $50 monthly copay through the end of 2027.
Does Medicaid cover Wegovy in my state? Maybe. Roughly 13 to 19 states currently cover it for weight loss, and that list keeps changing. Call your state Medicaid office to confirm.
My Honest Take
Coverage for Wegovy got worse this year, not better, and that’s rough for a drug this expensive. If your insurance covers it, use it. The copay will almost always beat any cash price. If it doesn’t, NovoCare’s direct pricing is where I’d look first, since there’s no membership fee stacked on top. That said, if fighting your insurance company alone sounds exhausting, a service like Ro that does some of that legwork might be worth the membership cost. Talk to your doctor about which FDA-approved indication actually applies to you before you assume the answer is no.
